Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases. 1995

C Tsurumi, and N Ishida, and T Tamura, and A Kakizuka, and E Nishida, and E Okumura, and T Kishimoto, and M Inagaki, and K Okazaki, and N Sagata
Institute for Enzyme Research, University of Tokushima, Japan.

c-Fos is associated with c-Jun to increase the transcription of a number of target genes and is a nuclear proto-oncoprotein with a very short half-life. This instability of c-Fos may be important in regulation of the normal cell cycle. Here we report a mechanism for degradation of c-Fos. Coexpression of c-Fos and c-Jun in HeLa cells caused marked increase in the instability of c-Fos, whereas v-Fos, the retroviral counterpart of c-Fos, was stable irrespective of the coexpression of c-Jun. Interestingly, deletion of the C-terminal PEST region of c-Fos, which is altered in v-Fos by a frameshift mutation, greatly enhanced its stability, with loss of the effect of c-Jun on its stability. c-Fos synthesized in vitro was degraded by the 26S proteasome in a ubiquitin-dependent fashion. Simple association with c-Jun had no effect on the degradation of c-Fos, but the additions of three protein kinases, mitogen-activated protein kinase, casein kinase II, and CDC2 kinase, resulted in marked acceleration of its degradation by the proteasome-ubiquitin system, though only in the presence of c-Jun. In contrast, v-Fos and c-Fos with a truncated PEST motif were not degraded, suggesting that they escaped from down-regulation by breakdown. These findings indicate a new oncogenic pathway induced by acquisition of intracellular stability of a cell cycle modulatory factor.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010447 Peptide Hydrolases Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D014452 Ubiquitins A family of proteins that are structurally-related to Ubiquitin. Ubiquitins and ubiquitin-like proteins participate in diverse cellular functions, such as protein degradation and HEAT-SHOCK RESPONSE, by conjugation to other proteins. Ubiquitin-Like Protein,Ubiquitin-Like Proteins,Protein, Ubiquitin-Like,Proteins, Ubiquitin-Like,Ubiquitin Like Protein,Ubiquitin Like Proteins
D016368 Frameshift Mutation A type of mutation in which a number of NUCLEOTIDES deleted from or inserted into a protein coding sequence is not divisible by three, thereby causing an alteration in the READING FRAMES of the entire coding sequence downstream of the mutation. These mutations may be induced by certain types of MUTAGENS or may occur spontaneously. Mutation, Frameshift,Frame Shift Mutation,Out-of-Frame Deletion,Out-of-Frame Insertion,Out-of-Frame Mutation,Deletion, Out-of-Frame,Deletions, Out-of-Frame,Frame Shift Mutations,Frameshift Mutations,Insertion, Out-of-Frame,Insertions, Out-of-Frame,Mutation, Frame Shift,Mutation, Out-of-Frame,Mutations, Frame Shift,Mutations, Frameshift,Mutations, Out-of-Frame,Out of Frame Deletion,Out of Frame Insertion,Out of Frame Mutation,Out-of-Frame Deletions,Out-of-Frame Insertions,Out-of-Frame Mutations
D016755 Proto-Oncogene Proteins c-jun Cellular DNA-binding proteins encoded by the c-jun genes (GENES, JUN). They are involved in growth-related transcriptional control. There appear to be three distinct functions: dimerization (with c-fos), DNA-binding, and transcriptional activation. Oncogenic transformation can take place by constitutive expression of c-jun. c-fos-Associated Protein p39,c-jun Proteins,fos-Associated Protein p39,jun B Proteins,jun D Proteins,jun Proto-Oncogene Proteins,p39(c-jun),Proto-Oncogene Products c-jun,Proto-Oncogene Proteins jun,jun Proto-Oncogene Product p39,p39 c-jun,Proto Oncogene Products c jun,Proto Oncogene Proteins c jun,Proto Oncogene Proteins jun,c fos Associated Protein p39,c jun Proteins,fos Associated Protein p39,jun Proto Oncogene Product p39,jun Proto Oncogene Proteins,p39 c jun
D016760 Proto-Oncogene Proteins c-fos Cellular DNA-binding proteins encoded by the c-fos genes (GENES, FOS). They are involved in growth-related transcriptional control. c-fos combines with c-jun (PROTO-ONCOGENE PROTEINS C-JUN) to form a c-fos/c-jun heterodimer (TRANSCRIPTION FACTOR AP-1) that binds to the TRE (TPA-responsive element) in promoters of certain genes. Fos B Protein,Fos-Related Antigen,Fos-Related Antigens,c-fos Protein,c-fos Proteins,fos Proto-Oncogene Protein,fos Proto-Oncogene Proteins,p55(c-fos),Antigens, Fos-Related,FRAs,Proto-Oncogene Products c-fos,Proto-Oncogene Proteins fos,p55 c-fos,Antigen, Fos-Related,Fos Related Antigen,Fos Related Antigens,Protein, c-fos,Protein, fos Proto-Oncogene,Proto Oncogene Products c fos,Proto Oncogene Proteins c fos,Proto Oncogene Proteins fos,Proto-Oncogene Protein, fos,c fos Protein,c fos Proteins,fos Proto Oncogene Protein,fos Proto Oncogene Proteins,p55 c fos
D016761 Oncogene Proteins v-fos Transforming proteins coded by fos oncogenes. These proteins have been found in the Finkel-Biskis-Jinkins (FBJ-MSV) and Finkel-Biskis-Reilly (FBR-MSV) murine sarcoma viruses which induce osteogenic sarcomas in mice. The FBJ-MSV v-fos gene encodes a p55-kDa protein and the FBR-MSV v-fos gene encodes a p75-kDa fusion protein. Fusion Proteins, gag-fos-fox,Oncogene Protein p55(v-fos),Oncogene Protein p75(gag-fos-fox),fos Oncogene Proteins,p55(v-fos),p75(gag-fos-fox),v-fos Proteins,Oncogene Products v-fos,Oncogene Proteins fos,p75 gag-fos,p75 gag-fos-fox,p75(gag-fos),Oncogene Products v fos,Oncogene Proteins v fos,gag-fos-fox Fusion Proteins,p75 gag fos,p75 gag fos fox,v fos Proteins

Related Publications

C Tsurumi, and N Ishida, and T Tamura, and A Kakizuka, and E Nishida, and E Okumura, and T Kishimoto, and M Inagaki, and K Okazaki, and N Sagata
August 2007, Biochemical and biophysical research communications,
C Tsurumi, and N Ishida, and T Tamura, and A Kakizuka, and E Nishida, and E Okumura, and T Kishimoto, and M Inagaki, and K Okazaki, and N Sagata
October 2008, Biochemical Society transactions,
C Tsurumi, and N Ishida, and T Tamura, and A Kakizuka, and E Nishida, and E Okumura, and T Kishimoto, and M Inagaki, and K Okazaki, and N Sagata
August 1996, Proceedings of the National Academy of Sciences of the United States of America,
C Tsurumi, and N Ishida, and T Tamura, and A Kakizuka, and E Nishida, and E Okumura, and T Kishimoto, and M Inagaki, and K Okazaki, and N Sagata
April 2021, Biochemical Society transactions,
C Tsurumi, and N Ishida, and T Tamura, and A Kakizuka, and E Nishida, and E Okumura, and T Kishimoto, and M Inagaki, and K Okazaki, and N Sagata
August 1991, FEBS letters,
C Tsurumi, and N Ishida, and T Tamura, and A Kakizuka, and E Nishida, and E Okumura, and T Kishimoto, and M Inagaki, and K Okazaki, and N Sagata
May 2004, FEBS letters,
C Tsurumi, and N Ishida, and T Tamura, and A Kakizuka, and E Nishida, and E Okumura, and T Kishimoto, and M Inagaki, and K Okazaki, and N Sagata
April 2000, Journal of virology,
C Tsurumi, and N Ishida, and T Tamura, and A Kakizuka, and E Nishida, and E Okumura, and T Kishimoto, and M Inagaki, and K Okazaki, and N Sagata
April 1999, Molecular biology reports,
C Tsurumi, and N Ishida, and T Tamura, and A Kakizuka, and E Nishida, and E Okumura, and T Kishimoto, and M Inagaki, and K Okazaki, and N Sagata
May 1995, The Journal of biological chemistry,
C Tsurumi, and N Ishida, and T Tamura, and A Kakizuka, and E Nishida, and E Okumura, and T Kishimoto, and M Inagaki, and K Okazaki, and N Sagata
January 2000, Biochemical and biophysical research communications,
Copied contents to your clipboard!